News
‘COVIDASHA’, a technology shot to battle the 2nd wave of the pandemic
CovidAsha, a chatbot platform on the Web, WhatsApp and Telegram, is a unique initiative by conversational automation heavy-weights Engati, and healthcare ecosystem players like...
News
Onyx Scientific bolsters manufacturing capabilities with commercial API license
Onyx Scientific, a small molecule API contract development and manufacturing organisation has received a commercial API license for its UK facility.
The license, granted by...
News
Global exclusive as Iceni Diagnostics licences key virus detection IP from University of Warwick
Iceni Diagnostics, a specialist carbohydrate chemistry company based in Norwich, is delighted to announce that it has agreed an exclusive global licence, to integrate...
Industry Reports
Analysis of more than 160,000 COVID-19 patients shows obesity is the biggest indicator for severity of infection in under 40s
Virtual clinical development specialist, Phesi Inc., has today released findings from a significant analysis of COVID-19 patient profiles; based on data from 166,239 COVID-19...
Drug Research
Pacira BioSciences, Inc. partners with Ashfield Engage to deliver European commercial infrastructure
Ashfield Engage, part of UDG Healthcare plc, announced that it has been selected by US-based Pacira BioSciences, Inc. to provide strategic commercialization services for...
Press Releases
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate
Samsung Biologics, the world’s leading contract development and manufacturing organization, signed a strategic partnership with KAHR Medical Ltd., a cancer immunotherapy company developing novel...
Press Releases
ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain
Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read